OIS Podcast | Ophthalmology's leading Podcast

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

OIS Podcast | Ophthalmology's leading Podcast is a business podcast hosted by Unknown Host, with 436 episodes on record and a Required Pod Score of 80.

Unknown Host hosts OIS Podcast | Ophthalmology's leading Podcast, a business show with 436 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #433

  The Pediatric Treatment Gap in Inherited Retinal Diseases

  Sep 8, 20269 min

  Inherited retinal diseases can profoundly affect a child’s vision and development, yet there are no approved drug treatments for most of these conditions in children. In this episode of Eye on Innovation, host Carey Powers speaks with Carmen Carrichio, CEO and founder of Raresight, about why pediatric inherited retinal diseases have historically received less attention and investment than adult diseases — and how advances in genetic testing and clinical assessment are beginning to change that. In this episode, learn about: Why treatments developed for adults cannot simply be applied to children Where gene therapy may fit into the future of care Raresight’s approach to developing treatments designed to remain in the eye longer How these treatments will change the trajectory of a child’s life RESOURCES: Carey Powers: Carey Powers, MBA | Ophthalmology Innovation Source

  ListenShow Notes
• 

  Episode #431

  Trial by Fire: Designing and Executing Ophthalmic Studies That Deliver

  Jul 7, 202637 min

  PANELIST (TITLE and AFFILIATION): Richard L. Beckman, M.D., Principal, RLB, M.D. Consulting, LLC Malvina Eydelman, M.D., CEO, The Collaborative Community on Ophthalmic Innovation MODERATOR: Barbara Wirostko, M.D., FARVO, CMO and Co-Founder, Qlaris Bio Description: How should you design your first-in-human study? Richard L. Beckman, M.D., principal of RLB, M.D. Consulting, LLC, and Malvina Eydelman, M.D., CEO of the Collaborative Community on Ophthalmic Innovation, sit down on a panel at OIS Ignite 2025, moderated by Barbara Wirostko, M.D., FARVO, CMO and co-founder, Qlaris Bio, to discuss what goes into designing first-in-human studies, including the preclinical work, the right people to advise you, and considering the population and patients. Also, stay tuned for updates on the next OIS Ignite, taking place on March 2027! In this episode, learn about: How the FDA can help and if it’s ever “too early” to reach out to them The FDA’s perspective Establishing a target product profile If a DSMB is recommended for trials RESOURCES: Barbara Wirostko: https://ois.net/barbara-wirostko-md-farvo/ Richard L. Beckman: https://ois.net/richard-rick-l-beckman-md/ Malvina Eydelman: https://ois.net/malvina-eydelman/

  ListenShow Notes
• 

  Episode #430

  Leaving a Global Footprint on Eye Care

  Jun 2, 20269 minS0

  <p>Gordon Bethwaite, head of marketing of eye care at Viatris, joins the Eye on Innovation podcast with host Carey Powers, M.B.A. to discuss Viatris’ footprint and impact on ophthalmology on a global scale. Bethwaite shares details on the company’s overall strategic vision for eye care, their fifth anniversary, and how it handles the “noisy category” that is dry eye.</p><p> </p><p>In this episode, learn about: </p>Viatris’ acquisitions and license agreements with different companiesWhat Tyrvaya brings to the table for clinicians and patientsHow Viatris is tackling unmet marketsWhat innovation means to Viatris in the context...

  ListenShow Notes
• 

  Episode #429

  Corneal Health Innovations and Therapeutics

  May 11, 202614 minS0

  <p>Rakhi Melvani, M.D., board-certified cornea and cataract and refractive surgeon at Gordon Schanzlin New Vision Institute, joins the Eye on Innovation podcast with host Carey Powers, M.B.A. to discuss innovative corneal treatments and how they’re changing the way patients receive treatment. Their conversation explores the FDA approval of Epioxa, an epithelium-on corneal collagen cross-linking therapy to treat progressive keratoconus, as well as refractive surgery and dry eye therapies.  </p><p> </p><p>In this episode, learn about:  </p>Ray tracing-based customization technology and how it’s different from Lasik Collagen mimetic peptides and how they work ST1...

  ListenShow Notes
• 

  Episode #428

  How Interventional Glaucoma is Advancing Eye Care

  Apr 14, 202616 minS0

  <p>Ehsan Sadri, M.D., CEO and founder of Visionary Eye Institute, joins the Eye on Innovation podcast to discuss the advancements of interventional glaucoma. With host Carey Powers, their conversation delves into how Sadri has changed patient care and management, the advancements he’s most excited for, and his thoughts on those who have yet to adopt interventional glaucoma as a practice mainstay. </p><p> </p><p>In this episode, learn about:  </p>The burden of drops on practices The characteristics to look for when choosing a minimally invasive procedure Metrics to evaluate success for interventional glaucoma procedures How patient...

  ListenShow Notes

Recent guests on OIS Podcast | Ophthalmology's leading Podcast. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.